Funds holding OnKure Therapeutics Inc
ISIN US68277Q1058 · United States
- Fund holders
- 13
- Of which ETFs
- 3 10 other funds
- Value held
- 2.9M $
- Share of capital
- 1.8 % of 40.5M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 510,161 | 2.1M $ | 0.00 % | 1.26 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 72,316 | 299.4K $ | 0.00 % | 0.18 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 37,199 | 100.8K $ | 0.00 % | 0.09 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 27,825 | 115.2K $ | 0.01 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 21,147 | 111.4K $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 17,178 | 46.6K $ | 0.04 % | as of Feb 28, 2026 ↗ | |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 16,293 | 67.5K $ | 0.08 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 11,068 | 30K $ | 0.03 % | as of Feb 28, 2026 ↗ | |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 2,807 | 14.8K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 1,762 | 7.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 1,087 | 2.9K $ | 0.00 % | as of Feb 28, 2026 ↗ | |
| Avantis Total Equity Markets ETF American Century ETF Trust | 504 | 1.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 370 | 1.5K $ | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 0.08 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 13 | +1 | 719,717 | +2.7 % |
| 2026Q1 | 12 | -3 | 700,469 | -13.0 % |
| 2025Q4 | 15 | -2 | 805,070 | -9.5 % |
| 2025Q3 | 17 | -2 | 889,964 | +2.4 % |
| 2025Q2 | 19 | +1 | 868,788 | +9.0 % |
| 2025Q1 | 18 | 797,106 |
Institutional managers
47 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 3,998,333 | 16.6M $ | as of Mar 31, 2026 |
| ACORN CAPITAL ADVISORS, LLC | 2,839,674 | 11.8M $ | as of Mar 31, 2026 |
| StepStone Group LP | 2,660,612 | 11M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 2,434,941 | 10.1M $ | as of Mar 31, 2026 |
| Prosight Management, LP | 2,154,381 | 8.9M $ | as of Mar 31, 2026 |
| BVF INC/IL | 1,978,972 | 8.2M $ | as of Mar 31, 2026 |
| Vivo Capital, LLC | 1,927,710 | 8M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 1,839,819 | 7.6M $ | as of Mar 31, 2026 |
| Foresite Capital Management VI LLC | 1,445,783 | 6M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,204,819 | 5M $ | as of Mar 31, 2026 |
| Sio Capital Management, LLC | 1,078,965 | 4.5M $ | as of Mar 31, 2026 |
| NEA Management Company, LLC | 478,548 | 2M $ | as of Mar 31, 2026 |
| Rosalind Advisors, Inc. | 443,763 | 1.8M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 377,250 | 1.6M $ | as of Mar 31, 2026 |
| Carlyle Group Inc. | 269,895 | 1.1M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 240,963 | 997.6K $ | as of Mar 31, 2026 |
| Sofinnova Investments, Inc. | 141,700 | 586.6K $ | as of Mar 31, 2026 |
| Stonepine Capital Management, LLC | 132,578 | 548.9K $ | as of Mar 31, 2026 |
| Shay Capital LLC | 132,219 | 547.4K $ | as of Mar 31, 2026 |
| CANTOR FITZGERALD, L. P. | 99,900 | 413.6K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 98,750 | 408.8K $ | as of Mar 31, 2026 |
| Rangeley Capital, LLC | 95,000 | 393.3K $ | as of Mar 31, 2026 |
| Aisling Capital Management LP | 88,607 | 366.8K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 49,587 | 205.3K $ | as of Mar 31, 2026 |
| NewEdge Advisors, LLC | 44,551 | 44.6K $ | as of Mar 31, 2026 |
Declared shareholders of OnKure Therapeutics Inc
There are 7 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| AI Biotechnology LLC and 3 others | 19.99 % | 9,091,532 | as of Mar 31, 2026 · SCHEDULE 13D |
| RA Capital Management, L.P. and 3 others | 9.90 % | 4,038,715 | as of Mar 31, 2026 · SCHEDULE 13G |
| ACORN BIOVENTURES, L.P. and 4 others | 9.50 % | 3,924,037 | as of Mar 27, 2026 · SCHEDULE 13G |
| StepStone Group LP and 2 others | 6.60 % | 2,660,612 | as of Mar 31, 2026 · SCHEDULE 13G |
| ADAR1 Capital Management, LLC and 2 others | 6.00 % | 2,434,941 | as of Mar 31, 2026 · SCHEDULE 13G |
| Trails Edge Capital Partners, LP and 2 others | 6.00 % | 2,409,638 | as of Mar 31, 2026 · SCHEDULE 13G |
| BIOTECHNOLOGY VALUE FUND L P and 9 others | 5.30 % | 2,134,908 | as of May 19, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding OnKure Therapeutics Inc". https://titelia.com/en/stocks/onkure-therapeutics-inc-US68277Q1058